SV

Satya Vani Mamidisetti

Active Director Director DIN 09070422
DIN 09070422 First appointment Feb 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2021
Shareholding value •••• Premium profile

About Satya Vani Mamidisetti

Data last updated:

Satya Vani Mamidisetti is a Director at Aytas Pharmaceutical Private Limited (since 2021). The company operates in Pharma. Aytas Pharmaceutical Private Limited reported revenue of ₹2.15 Cr (FY 2023).

DIN 09070422
Primary Designation Director
Industry Pharma
First Appointment 18 Feb 2021
Oldest Company Age 9 yrs
Largest company Aytas Pharmaceutical Private Limited · ₹2.15 Cr (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aytas Pharmaceutical Private Limited U24299TG2017PTC118007
Director18 Feb 20212017₹2.15 Cr (FY 2023)Active

Board colleagues of Satya Vani Mamidisetti

Directorship timeline

Open interactive timeline →
Aytas Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Satya Vani Mamidisetti

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Satya Vani Mamidisetti

Satya Vani Mamidisetti currently holds 1 directorship: Aytas Pharmaceutical Private Limited (Director, since 18 Feb 2021, revenue ₹2.15 Cr (FY 2023)).

Satya Vani Mamidisetti was first appointed on 18 Feb 2021 as Director at Aytas Pharmaceutical Private Limited.

The current boards of Satya Vani Mamidisetti's companies include Vvsatyanarayana Veera Venkata Mamidisetti (Aytas Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available